Literature DB >> 27149207

Small-molecule approaches toward the targeting of oncogenic miRNAs: roadmap for the discovery of RNA modulators.

Audrey Di Giorgio1, Thi Phuong Anh Tran1, Maria Duca1.   

Abstract

miRNAs are a recently discovered class of small noncoding RNAs implicated in the regulation of gene expression. The deregulation of miRNAs levels has been linked to the development of various cancers where oncogenic miRNAs are overexpressed and tumor suppressor miRNAs are underexpressed. Here we report the three main strategies developed in order to discover small-molecule drugs able to selectively interfere with oncogenic miRNAs: the high throughput screening of large libraries of compounds, the focused screening of small libraries of molecules that are known to be able to interact with RNA thus being supposed modulators of miRNAs pathway and the design of small molecules based on the secondary structure of targeted RNA and/or three-dimensional structure of enzymes involved in miRNAs pathway.

Entities:  

Keywords:  inhibitor; oncogenic miRNA; small molecule

Mesh:

Substances:

Year:  2016        PMID: 27149207     DOI: 10.4155/fmc-2016-0018

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  13 in total

Review 1.  Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics.

Authors:  Rengen Fan; Chaocheng Xiao; Xinqiang Wan; Wenzhang Cha; Yufeng Miao; Yong Zhou; Chenglin Qin; Ting Cui; Fenglian Su; Xiangxiang Shan
Journal:  RNA Biol       Date:  2019-04-03       Impact factor: 4.652

Review 2.  Drugging the "undruggable" microRNAs.

Authors:  Dejun Liu; Xinqiang Wan; Xiangxiang Shan; Rengen Fan; Wenzhang Zha
Journal:  Cell Mol Life Sci       Date:  2020-10-14       Impact factor: 9.261

3.  SNMFSMMA: using symmetric nonnegative matrix factorization and Kronecker regularized least squares to predict potential small molecule-microRNA association.

Authors:  Yan Zhao; Xing Chen; Jun Yin; Jia Qu
Journal:  RNA Biol       Date:  2019-11-27       Impact factor: 4.652

Review 4.  Synthetic small-molecule RNA ligands: future prospects as therapeutic agents.

Authors:  A Di Giorgio; M Duca
Journal:  Medchemcomm       Date:  2019-04-30       Impact factor: 3.597

5.  The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment.

Authors:  Erez Uzuner; Gizem Tugçe Ulu; Sevim Beyza Gürler; Yusuf Baran
Journal:  Methods Mol Biol       Date:  2022

6.  Development of 2-deoxystreptamine-nucleobase conjugates for the inhibition of oncogenic miRNA production.

Authors:  Thi Phuong Anh Tran; Sylvain Poulet; Mélanie Pernak; Anita Rayar; Stéphane Azoulay; Audrey Di Giorgio; Maria Duca
Journal:  RSC Med Chem       Date:  2021-12-16

Review 7.  Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.

Authors:  Dinh-Duc Nguyen; Suhwan Chang
Journal:  Int J Mol Sci       Date:  2017-12-27       Impact factor: 5.923

8.  Cell-Based Reporter System for High-Throughput Screening of MicroRNA Pathway Inhibitors and Its Limitations.

Authors:  Katerina Brustikova; David Sedlak; Jana Kubikova; Ctibor Skuta; Katerina Solcova; Radek Malik; Petr Bartunek; Petr Svoboda
Journal:  Front Genet       Date:  2018-02-27       Impact factor: 4.599

9.  Modulation of oncogenic miRNA biogenesis using functionalized polyamines.

Authors:  Cathy Staedel; Thi Phuong Anh Tran; Julie Giraud; Fabien Darfeuille; Audrey Di Giorgio; Nicolas J Tourasse; Franck Salin; Philippe Uriac; Maria Duca
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379

Review 10.  Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates.

Authors:  Santiago Grijalvo; Adele Alagia; Andreia F Jorge; Ramon Eritja
Journal:  Genes (Basel)       Date:  2018-02-06       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.